Testosterone Injections and Nocturia: No Direct Causal Link Established
Testosterone replacement therapy does not cause increased nocturia in men; in fact, evidence suggests it may improve nocturia in hypogonadal men. The available research indicates that testosterone deficiency itself is associated with nocturia, and testosterone treatment can ameliorate this symptom rather than worsen it.
The Evidence on Testosterone and Nocturia
Testosterone May Improve Nocturia
The most relevant research directly addressing this question found that testosterone replacement therapy actually improved nocturia in hypogonadal men 1. In this prospective randomized controlled study, men with hypogonadism and nocturia who received 250 mg testosterone enanthate intramuscularly every 4 weeks for 6 months showed significant improvement in nighttime urination frequency and sleep quality compared to controls.
A comprehensive review further supports this, noting that testosterone deficiency is significantly associated with nocturia, and testosterone has an ameliorative effect on this symptom 2. The review describes a negative feedback cycle where testosterone deficiency leads to nocturia, which in turn contributes to further decline in testosterone levels through sleep disruption.
Recent population-level data confirms this relationship: testosterone deficiency is positively correlated with nocturia, particularly in elderly men and those with cardiovascular disease 3. The study found a U-shaped pattern between testosterone levels and nocturia risk, with deficiency increasing the odds of nocturia.
Guideline Perspective on Lower Urinary Tract Symptoms
The major clinical practice guidelines address prostate-related concerns but do not identify nocturia as a side effect of testosterone therapy:
- The 2010 Endocrine Society guidelines recommend monitoring for worsening lower urinary tract symptoms 4, specifically obtaining urological consultation if the AUA/IPSS score exceeds 19
- The guidelines note that benign prostatic hyperplasia is a relative contraindication to testosterone therapy 5
- However, a 2004 review found that multiple studies failed to demonstrate exacerbation of voiding symptoms during testosterone supplementation 6
Clinical Implications
When to Consider Testosterone's Role
If a patient on testosterone injections develops or reports worsening nocturia, consider:
- Evaluate for prostate enlargement: Check prostate size via digital rectal examination and PSA levels as recommended in monitoring protocols 4
- Assess for polycythemia: Testosterone can cause erythrocytosis (particularly with intramuscular injections), which theoretically could affect blood viscosity, though this has not been linked to nocturia 6
- Look for other causes: Sleep apnea (which testosterone may worsen), fluid retention, or unrelated urological conditions 5
Monitoring Recommendations
Per Endocrine Society guidelines 4, 7:
- Check hematocrit at baseline, 3-6 months, then annually
- Perform digital rectal examination and PSA at baseline, 3-6 months, then per age-appropriate screening
- Obtain urology consultation if AUA/IPSS score >19
- Evaluate for sleep apnea if hematocrit >54%
Important Caveats
The relationship between testosterone and nocturia appears paradoxical: while testosterone deficiency is associated with nocturia, testosterone therapy generally improves rather than worsens this symptom. The mechanism likely involves testosterone's effects on sleep quality, bladder function, and overall metabolic health.
Intramuscular formulations (which the question specifically asks about) have similar efficacy to transdermal preparations for most outcomes 8, though they carry higher risk of erythrocytosis 6. The FDA-approved dosing for intramuscular testosterone cypionate is 50-400 mg every 2-4 weeks 9.
If nocturia develops or worsens on testosterone therapy, this is more likely due to prostate enlargement, sleep apnea, or other comorbidities rather than a direct effect of testosterone itself. The evidence does not support discontinuing testosterone solely for nocturia unless other contraindications emerge.